Login
$CENN
$2.64 +$0.30 (12.82%) Close

Unaudited condensed consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Jan 31, 2021
Q4 FY2019
As of Jan 31, 2020
Q4 FY2018
As of Jan 31, 2019
Q4 FY2017
As of Jan 31, 2018
Current assets:
Cash and cash equivalents
Restricted cash, current
Short-term investment
Accounts receivable, net
Inventories, net
Prepayment and other current assets
Deferred cost - current
Amounts due from related parties, current
Assets held for sale, current
Total current assets
Non-current assets:
Long-term time deposit
Long-term investments
Investment in equity security
Investment in equity securities
Property, plant and equipment, net
Intangible assets, net
Right-of-use assets
Deferred cost - non-current
Other non-current assets, net
Assets held for sale, non-current
Total non-current assets
Total Assets
Current liabilities:
Accounts payable
Short-term loans and current portion of long-term loans
Accrued expenses and other current liabilities
Contract liabilities
Operating lease liabilities, current
Convertible promissory notes
Contingent liabilities
Deferred government grant, current
Amounts due to a related party
Liabilities held for sale, current
Total current liabilities
Non-current liabilities:
Long-term loans
Contingent liabilities non-current
Deferred tax liabilities
Deferred government grant, non-current
Derivative liability - investor warrant
Derivative liability - placement agent warrant
Operating lease liabilities, non-current
Total non-current liabilities
Total Liabilities
EQUITY
Common stock ($0.0001 par value; 3,000,000,000 shares authorized; 2,465,452 and 1,465,214 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) *
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive loss
Total equity attributable to shareholders
Non-controlling interests
Total Equity
Total Liabilities and Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support